<DOC>
	<DOCNO>NCT02744378</DOCNO>
	<brief_summary>This clinical study carry assess efficacy Tacrolimus Clobetasol symptomatic Oral Lichen Planus .</brief_summary>
	<brief_title>Comparison Tacrolimus 0.1 % Clobetasol 0.05 % Management Symptomatic Oral Lichen Planus</brief_title>
	<detailed_description />
	<mesh_term>Lichen Planus , Oral</mesh_term>
	<mesh_term>Lichen Planus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Clinically Histologically proven Oral Lichen Planus Symptomatic topical/ systemic medication OLP previous three month contraindication medication use history allergy either corticosteroids/ tacrolimus immunosuppression , pregnant / lactate female lichenoid reaction either drug induced due dental amalgam diabetes mellitus oral hypoglycemic drug systemic involvement concurrent skin/genital lesion</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>